Additionally, the treatment diminishes the presence of virus-induced PD-L1+ dendritic cells, myeloid-derived suppressor cells, tumor-associated macrophages, and regulatory T cells, as well as double-positive, highly exhausted PD-1+CD8+ T cells. Here, CD8A is linked to neoplasm.